Dr. Saikat Kumar Ghosh is a Technology Transfer Agreements Specialist in the Technology Partnerships Office (TPO) of the National Institute of Standards and Technology (NIST), where he works primarily on collaborations and agreements for NIST’s Communications Technology Laboratory and the Material Measurement Laboratory.
Saikat has more than 27 years of scientific research experience in biochemistry, molecular biology, biotechnology, microbiology, and cell biology. He is experienced in managing programs, grants, projects, subcontracts, subawards, and administrative reviews.
Before coming to NIST, Saikat was a Technology Transfer Specialist at the Walter Reed National Military Medical Center, where he crafted and oversaw research and clinical trial collaborative agreements with federal and non-federal partners. As Head of the Molecular Biology Laboratory and Senior Research Scientist at the CVPath Institute, Dr. Ghosh directed cardiovascular diseases research. While a Senior Scientist at Medigen Inc., Saikat worked on the development and manufacturing of vaccines against emerging infectious diseases and chronic diseases.
As a Research Molecular Biologist at the US Department of Agriculture, Dr. Ghosh focused on developing molecular biopesticides against invasive insect pests. His multiple patents have a global reach. These patents use RNAi-mediated gene silencing and dsRNA delivery methods to reduce invasive insect pests.
Saikat received a doctorate in Biochemistry, Microbiology, and Molecular Biology from the Pennsylvania State University, a Master of Science in Life Sciences specializing in Biological Macromolecules from the University of Mumbai, India, and a Bachelor of Science in Life Sciences specializing in Biotechnology from St. Xavier’s College, Mumbai, India.
Dr. Ghosh has completed two Postdoctoral fellowships. While a fellow at the Pennsylvania State University, he designed a study to characterize the intricacies of protein-RNA interactions regulating gene expression in human cells. He also studied proteins that regulate vascular intimal hyperplasia while a fellow at the University of Maryland’s School of Medicine.